nodes	percent_of_prediction	percent_of_DWPC	metapath
Paliperidone—Oligomenorrhoea—Octreotide—thymus cancer	0.0631	0.0722	CcSEcCtD
Paliperidone—HTR2A—phrenic nerve—thymus cancer	0.0384	0.307	CbGeAlD
Paliperidone—Pruritus generalised—Octreotide—thymus cancer	0.0293	0.0334	CcSEcCtD
Paliperidone—Breast feeding—Octreotide—thymus cancer	0.028	0.0319	CcSEcCtD
Paliperidone—Ischaemia—Octreotide—thymus cancer	0.0268	0.0306	CcSEcCtD
Paliperidone—Ear infection—Octreotide—thymus cancer	0.023	0.0263	CcSEcCtD
Paliperidone—Pregnancy—Octreotide—thymus cancer	0.0172	0.0197	CcSEcCtD
Paliperidone—Transaminases increased—Octreotide—thymus cancer	0.0161	0.0183	CcSEcCtD
Paliperidone—Galactorrhoea—Octreotide—thymus cancer	0.0151	0.0172	CcSEcCtD
Paliperidone—Redness—Octreotide—thymus cancer	0.0145	0.0165	CcSEcCtD
Paliperidone—Intestinal obstruction—Octreotide—thymus cancer	0.0143	0.0164	CcSEcCtD
Paliperidone—Seborrhoeic dermatitis—Octreotide—thymus cancer	0.0143	0.0164	CcSEcCtD
Paliperidone—Menstrual disorder—Octreotide—thymus cancer	0.0143	0.0164	CcSEcCtD
Paliperidone—Blood creatine phosphokinase increased—Octreotide—thymus cancer	0.0142	0.0162	CcSEcCtD
Paliperidone—HTR2A—pulmonary artery—thymus cancer	0.0139	0.111	CbGeAlD
Paliperidone—HTR2A—vein—thymus cancer	0.0127	0.101	CbGeAlD
Paliperidone—Injection site pain—Octreotide—thymus cancer	0.012	0.0137	CcSEcCtD
Paliperidone—Endocrine disorder—Octreotide—thymus cancer	0.0118	0.0135	CcSEcCtD
Paliperidone—Acne—Octreotide—thymus cancer	0.0116	0.0133	CcSEcCtD
Paliperidone—Breast pain—Octreotide—thymus cancer	0.0112	0.0128	CcSEcCtD
Paliperidone—Amenorrhoea—Octreotide—thymus cancer	0.0111	0.0127	CcSEcCtD
Paliperidone—Viral infection—Octreotide—thymus cancer	0.0108	0.0124	CcSEcCtD
Paliperidone—Cellulitis—Octreotide—thymus cancer	0.0107	0.0123	CcSEcCtD
Paliperidone—Muscle twitching—Octreotide—thymus cancer	0.00995	0.0114	CcSEcCtD
Paliperidone—Injection site reaction—Octreotide—thymus cancer	0.00971	0.0111	CcSEcCtD
Paliperidone—Cystitis noninfective—Octreotide—thymus cancer	0.00954	0.0109	CcSEcCtD
Paliperidone—Wheezing—Octreotide—thymus cancer	0.00949	0.0108	CcSEcCtD
Paliperidone—Cystitis—Octreotide—thymus cancer	0.00943	0.0108	CcSEcCtD
Paliperidone—Bladder pain—Octreotide—thymus cancer	0.00883	0.0101	CcSEcCtD
Paliperidone—Gynaecomastia—Octreotide—thymus cancer	0.00874	0.00999	CcSEcCtD
Paliperidone—Hyperkinesia—Octreotide—thymus cancer	0.00852	0.00974	CcSEcCtD
Paliperidone—Sleep disorder—Octreotide—thymus cancer	0.00819	0.00936	CcSEcCtD
Paliperidone—Diabetes mellitus—Octreotide—thymus cancer	0.00815	0.00932	CcSEcCtD
Paliperidone—Gastroenteritis—Octreotide—thymus cancer	0.008	0.00914	CcSEcCtD
Paliperidone—Nasal congestion—Octreotide—thymus cancer	0.00778	0.00889	CcSEcCtD
Paliperidone—Hypoglycaemia—Octreotide—thymus cancer	0.00726	0.0083	CcSEcCtD
Paliperidone—Osteoarthritis—Octreotide—thymus cancer	0.00709	0.0081	CcSEcCtD
Paliperidone—Pain in extremity—Octreotide—thymus cancer	0.00709	0.0081	CcSEcCtD
Paliperidone—Dry skin—Octreotide—thymus cancer	0.0065	0.00743	CcSEcCtD
Paliperidone—Abdominal pain upper—Octreotide—thymus cancer	0.00648	0.0074	CcSEcCtD
Paliperidone—Nasopharyngitis—Octreotide—thymus cancer	0.00634	0.00725	CcSEcCtD
Paliperidone—Muscular weakness—Octreotide—thymus cancer	0.00625	0.00715	CcSEcCtD
Paliperidone—Influenza—Octreotide—thymus cancer	0.00613	0.007	CcSEcCtD
Paliperidone—Pancreatitis—Octreotide—thymus cancer	0.00601	0.00687	CcSEcCtD
Paliperidone—Bronchitis—Octreotide—thymus cancer	0.00589	0.00674	CcSEcCtD
Paliperidone—Abdominal discomfort—Octreotide—thymus cancer	0.00587	0.00671	CcSEcCtD
Paliperidone—Dysuria—Octreotide—thymus cancer	0.00573	0.00655	CcSEcCtD
Paliperidone—Upper respiratory tract infection—Octreotide—thymus cancer	0.00569	0.00651	CcSEcCtD
Paliperidone—Pollakiuria—Octreotide—thymus cancer	0.00566	0.00647	CcSEcCtD
Paliperidone—Weight increased—Octreotide—thymus cancer	0.00558	0.00637	CcSEcCtD
Paliperidone—Weight decreased—Octreotide—thymus cancer	0.00554	0.00634	CcSEcCtD
Paliperidone—Hyperglycaemia—Octreotide—thymus cancer	0.00553	0.00632	CcSEcCtD
Paliperidone—Pneumonia—Octreotide—thymus cancer	0.0055	0.00628	CcSEcCtD
Paliperidone—Depression—Octreotide—thymus cancer	0.00545	0.00623	CcSEcCtD
Paliperidone—Jaundice—Octreotide—thymus cancer	0.00533	0.00609	CcSEcCtD
Paliperidone—Conjunctivitis—Octreotide—thymus cancer	0.00531	0.00607	CcSEcCtD
Paliperidone—Urinary tract infection—Octreotide—thymus cancer	0.00531	0.00607	CcSEcCtD
Paliperidone—Hepatobiliary disease—Octreotide—thymus cancer	0.00517	0.00591	CcSEcCtD
Paliperidone—Epistaxis—Octreotide—thymus cancer	0.00515	0.00589	CcSEcCtD
Paliperidone—Sinusitis—Octreotide—thymus cancer	0.00513	0.00586	CcSEcCtD
Paliperidone—Bradycardia—Octreotide—thymus cancer	0.00499	0.00571	CcSEcCtD
Paliperidone—Rhinitis—Octreotide—thymus cancer	0.00492	0.00562	CcSEcCtD
Paliperidone—Hypoaesthesia—Octreotide—thymus cancer	0.00488	0.00558	CcSEcCtD
Paliperidone—Oedema peripheral—Octreotide—thymus cancer	0.00483	0.00552	CcSEcCtD
Paliperidone—Tinnitus—Octreotide—thymus cancer	0.00457	0.00523	CcSEcCtD
Paliperidone—Flushing—Octreotide—thymus cancer	0.00455	0.0052	CcSEcCtD
Paliperidone—Cardiac disorder—Octreotide—thymus cancer	0.00455	0.0052	CcSEcCtD
Paliperidone—Immune system disorder—Octreotide—thymus cancer	0.00443	0.00506	CcSEcCtD
Paliperidone—Alopecia—Octreotide—thymus cancer	0.00433	0.00495	CcSEcCtD
Paliperidone—Mental disorder—Octreotide—thymus cancer	0.0043	0.00491	CcSEcCtD
Paliperidone—Erythema—Octreotide—thymus cancer	0.00427	0.00488	CcSEcCtD
Paliperidone—Malnutrition—Octreotide—thymus cancer	0.00427	0.00488	CcSEcCtD
Paliperidone—Flatulence—Octreotide—thymus cancer	0.00421	0.00481	CcSEcCtD
Paliperidone—Tension—Octreotide—thymus cancer	0.00419	0.00479	CcSEcCtD
Paliperidone—Nervousness—Octreotide—thymus cancer	0.00415	0.00474	CcSEcCtD
Paliperidone—Back pain—Octreotide—thymus cancer	0.00413	0.00472	CcSEcCtD
Paliperidone—Muscle spasms—Octreotide—thymus cancer	0.0041	0.00469	CcSEcCtD
Paliperidone—Vision blurred—Octreotide—thymus cancer	0.00402	0.0046	CcSEcCtD
Paliperidone—Tremor—Octreotide—thymus cancer	0.004	0.00457	CcSEcCtD
Paliperidone—Ill-defined disorder—Octreotide—thymus cancer	0.00396	0.00453	CcSEcCtD
Paliperidone—Anaemia—Octreotide—thymus cancer	0.00395	0.00451	CcSEcCtD
Paliperidone—Agitation—Octreotide—thymus cancer	0.00392	0.00448	CcSEcCtD
Paliperidone—Malaise—Octreotide—thymus cancer	0.00385	0.0044	CcSEcCtD
Paliperidone—Vertigo—Octreotide—thymus cancer	0.00384	0.00438	CcSEcCtD
Paliperidone—Syncope—Octreotide—thymus cancer	0.00383	0.00438	CcSEcCtD
Paliperidone—Palpitations—Octreotide—thymus cancer	0.00377	0.00431	CcSEcCtD
Paliperidone—Loss of consciousness—Octreotide—thymus cancer	0.00375	0.00429	CcSEcCtD
Paliperidone—Cough—Octreotide—thymus cancer	0.00373	0.00426	CcSEcCtD
Paliperidone—Convulsion—Octreotide—thymus cancer	0.0037	0.00423	CcSEcCtD
Paliperidone—Hypertension—Octreotide—thymus cancer	0.00369	0.00421	CcSEcCtD
Paliperidone—Arthralgia—Octreotide—thymus cancer	0.00363	0.00415	CcSEcCtD
Paliperidone—Myalgia—Octreotide—thymus cancer	0.00363	0.00415	CcSEcCtD
Paliperidone—Chest pain—Octreotide—thymus cancer	0.00363	0.00415	CcSEcCtD
Paliperidone—Anxiety—Octreotide—thymus cancer	0.00362	0.00414	CcSEcCtD
Paliperidone—Unspecified disorder of skin and subcutaneous tissue—Octreotide—thymus cancer	0.00361	0.00413	CcSEcCtD
Paliperidone—HTR1A—hematopoietic system—thymus cancer	0.00359	0.0287	CbGeAlD
Paliperidone—Discomfort—Octreotide—thymus cancer	0.00359	0.0041	CcSEcCtD
Paliperidone—Dry mouth—Octreotide—thymus cancer	0.00355	0.00406	CcSEcCtD
Paliperidone—Oedema—Octreotide—thymus cancer	0.00348	0.00398	CcSEcCtD
Paliperidone—Anaphylactic shock—Octreotide—thymus cancer	0.00348	0.00398	CcSEcCtD
Paliperidone—Infection—Octreotide—thymus cancer	0.00346	0.00396	CcSEcCtD
Paliperidone—Shock—Octreotide—thymus cancer	0.00343	0.00392	CcSEcCtD
Paliperidone—Nervous system disorder—Octreotide—thymus cancer	0.00342	0.00391	CcSEcCtD
Paliperidone—Thrombocytopenia—Octreotide—thymus cancer	0.00341	0.0039	CcSEcCtD
Paliperidone—Tachycardia—Octreotide—thymus cancer	0.0034	0.00389	CcSEcCtD
Paliperidone—Skin disorder—Octreotide—thymus cancer	0.00338	0.00387	CcSEcCtD
Paliperidone—Anorexia—Octreotide—thymus cancer	0.00332	0.0038	CcSEcCtD
Paliperidone—ADRA1A—hematopoietic system—thymus cancer	0.00331	0.0265	CbGeAlD
Paliperidone—Musculoskeletal discomfort—Octreotide—thymus cancer	0.00317	0.00363	CcSEcCtD
Paliperidone—Insomnia—Octreotide—thymus cancer	0.00315	0.0036	CcSEcCtD
Paliperidone—Paraesthesia—Octreotide—thymus cancer	0.00313	0.00358	CcSEcCtD
Paliperidone—Dyspnoea—Octreotide—thymus cancer	0.00311	0.00355	CcSEcCtD
Paliperidone—Somnolence—Octreotide—thymus cancer	0.0031	0.00354	CcSEcCtD
Paliperidone—Dyspepsia—Octreotide—thymus cancer	0.00307	0.00351	CcSEcCtD
Paliperidone—Decreased appetite—Octreotide—thymus cancer	0.00303	0.00346	CcSEcCtD
Paliperidone—ADRA1A—epithelium—thymus cancer	0.00303	0.0242	CbGeAlD
Paliperidone—Gastrointestinal disorder—Octreotide—thymus cancer	0.00301	0.00344	CcSEcCtD
Paliperidone—Fatigue—Octreotide—thymus cancer	0.003	0.00343	CcSEcCtD
Paliperidone—Constipation—Octreotide—thymus cancer	0.00298	0.00341	CcSEcCtD
Paliperidone—Pain—Octreotide—thymus cancer	0.00298	0.00341	CcSEcCtD
Paliperidone—HTR2A—neck—thymus cancer	0.00288	0.023	CbGeAlD
Paliperidone—Feeling abnormal—Octreotide—thymus cancer	0.00287	0.00328	CcSEcCtD
Paliperidone—Gastrointestinal pain—Octreotide—thymus cancer	0.00285	0.00326	CcSEcCtD
Paliperidone—Urticaria—Octreotide—thymus cancer	0.00277	0.00316	CcSEcCtD
Paliperidone—Body temperature increased—Octreotide—thymus cancer	0.00275	0.00315	CcSEcCtD
Paliperidone—Abdominal pain—Octreotide—thymus cancer	0.00275	0.00315	CcSEcCtD
Paliperidone—CYP3A5—hematopoietic system—thymus cancer	0.00264	0.0211	CbGeAlD
Paliperidone—Hypersensitivity—Octreotide—thymus cancer	0.00257	0.00293	CcSEcCtD
Paliperidone—HRH1—hematopoietic system—thymus cancer	0.00256	0.0205	CbGeAlD
Paliperidone—ADRA2A—hematopoietic system—thymus cancer	0.00252	0.0201	CbGeAlD
Paliperidone—Asthenia—Octreotide—thymus cancer	0.0025	0.00286	CcSEcCtD
Paliperidone—Pruritus—Octreotide—thymus cancer	0.00247	0.00282	CcSEcCtD
Paliperidone—DRD2—pituitary gland—thymus cancer	0.00241	0.0193	CbGeAlD
Paliperidone—ADRA2C—cardiac atrium—thymus cancer	0.0024	0.0192	CbGeAlD
Paliperidone—Diarrhoea—Octreotide—thymus cancer	0.00238	0.00272	CcSEcCtD
Paliperidone—HRH1—epithelium—thymus cancer	0.00234	0.0187	CbGeAlD
Paliperidone—ADRA2C—pituitary gland—thymus cancer	0.00234	0.0187	CbGeAlD
Paliperidone—ADRA1A—lymphoid tissue—thymus cancer	0.00233	0.0186	CbGeAlD
Paliperidone—Dizziness—Octreotide—thymus cancer	0.0023	0.00263	CcSEcCtD
Paliperidone—Vomiting—Octreotide—thymus cancer	0.00222	0.00253	CcSEcCtD
Paliperidone—Rash—Octreotide—thymus cancer	0.0022	0.00251	CcSEcCtD
Paliperidone—Dermatitis—Octreotide—thymus cancer	0.0022	0.00251	CcSEcCtD
Paliperidone—Headache—Octreotide—thymus cancer	0.00218	0.00249	CcSEcCtD
Paliperidone—HTR2A—hematopoietic system—thymus cancer	0.00214	0.0171	CbGeAlD
Paliperidone—Nausea—Octreotide—thymus cancer	0.00207	0.00237	CcSEcCtD
Paliperidone—CYP3A4—hematopoietic system—thymus cancer	0.00198	0.0159	CbGeAlD
Paliperidone—HTR2A—epithelium—thymus cancer	0.00196	0.0157	CbGeAlD
Paliperidone—CYP2D6—hematopoietic system—thymus cancer	0.00195	0.0156	CbGeAlD
Paliperidone—ADRA2A—cardiac atrium—thymus cancer	0.00191	0.0153	CbGeAlD
Paliperidone—DRD2—lung—thymus cancer	0.00189	0.0151	CbGeAlD
Paliperidone—ADRA2A—pituitary gland—thymus cancer	0.00187	0.0149	CbGeAlD
Paliperidone—ADRA2C—lung—thymus cancer	0.00183	0.0147	CbGeAlD
Paliperidone—ADRA2A—thyroid gland—thymus cancer	0.00161	0.0129	CbGeAlD
Paliperidone—HTR2A—pituitary gland—thymus cancer	0.00159	0.0127	CbGeAlD
Paliperidone—CYP3A5—lung—thymus cancer	0.00153	0.0123	CbGeAlD
Paliperidone—HRH1—lung—thymus cancer	0.00149	0.0119	CbGeAlD
Paliperidone—ADRA2A—lung—thymus cancer	0.00146	0.0117	CbGeAlD
Paliperidone—ADRA2C—lymph node—thymus cancer	0.00125	0.01	CbGeAlD
Paliperidone—HTR2A—lung—thymus cancer	0.00124	0.00995	CbGeAlD
Paliperidone—HRH1—lymph node—thymus cancer	0.00102	0.00814	CbGeAlD
Paliperidone—ADRA2A—lymph node—thymus cancer	0.001	0.008	CbGeAlD
